A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia
NCT03875534 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 260
Last updated 2024-03-19
Summary
This is a long-term, multi-center, longitudinal, observational study in children with achondroplasia (ACH). The aim is to study height velocity and comorbidities in children with ACH. This is a natural history study and no study medication will be administered.
Conditions
Sponsors & Collaborators
-
Ascendis Pharma A/S
lead INDUSTRY
Eligibility
- Min Age
- 0 Years
- Max Age
- 8 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-19
- Primary Completion
- 2024-01-12
- Completion
- 2024-01-12
Countries
- United States
- Australia
- Austria
- Canada
- China
- Denmark
- France
- Germany
- Ireland
- Italy
- New Zealand
- Portugal
- Spain
- Switzerland
- United Kingdom
Study Locations
More Related Trials
-
The Norwegian Adult Achondroplasia Study
NCT03780153 ·Status: COMPLETED
-
A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
NCT06433557 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
NCT05353192 ·Status: UNKNOWN ·Phase: PHASE4
-
Prospective Clinical Assessment Study in Children With Hypochondroplasia
NCT06410976 ·Status: RECRUITING
-
Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)
NCT05328050 ·Status: RECRUITING
-
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
NCT06212947 ·Status: RECRUITING
-
Molecular Basis of the Growth Axis in Short Stature
NCT00453245 ·Status: COMPLETED
-
An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia
NCT03989947 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Lifetime Impact of Achondroplasia Study in Europe-LIAISE
NCT03449368 ·Status: COMPLETED
-
An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia
NCT03424018 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia
NCT07297875 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Skeletal Disorders and Short Stature
NCT00001754 ·Status: COMPLETED
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2
-
Achondroplasia Natural History Multicenter Clinical Study
NCT02597881 ·Status: RECRUITING
-
A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin
NCT01435629 ·Status: COMPLETED
-
A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia
NCT02055157 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.
NCT06732895 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia
NCT05598320 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With Achondroplasia
NCT05246033 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia
NCT05929807 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia
NCT06067425 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess Growth in Children With Idiopathic Short Stature
NCT06309979 ·Status: RECRUITING
-
A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia
NCT04085523 ·Status: COMPLETED ·Phase: PHASE2
-
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
NCT03972345 ·Status: ENROLLING_BY_INVITATION
-
A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia
NCT04638153 ·Status: TERMINATED ·Phase: PHASE2